EPP is a genetic disorder that causes a phototoxic ... Participants also had the option to continue in an open-label extension of the study for an additional 24 weeks. Disc plans to launch the ...

Disc is also running a 26-subject open-label phase 2 study of bitopertin in patients with EPP and XLP, called BEACON, which was reported at last year's American Society of Haematology (ASH ...